Compared with patients with private insurance, patients with Medicare, Medicaid, or without insurance had lower odds of receiving chemotherapy in 2010 to 2016 than in 2004 to 2009 ( Supplementary Table 1 ), indicating a decreasing trend of receiving chemotherapy for this group in recent years.
← all excerpts
Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC.
1
—
—